Endogenous IL-27 during toxoplasmosis limits early monocyte responses and their inflammatory activation by pathological T cells
Open Access
- 13 March 2024
- journal article
- research article
- Published by American Society for Microbiology in mBio
- Vol. 15 (3) , e0008324
Abstract
Mice that lack the genes for IL-27, or the IL-27 receptor, and infected with Toxoplasma gondii develop T cell-mediated pathology. Here, studies were performed to determine the impact of endogenous IL-27 on the immune response to T. gondii in wild-type (WT) mice. Analysis of infected mice revealed the early production of IL-27p28 by a subset of Ly6C hi , inflammatory monocytes, and sustained IL-27p28 production at sites of acute and chronic infection. Administration of anti-IL-27p28 prior to infection resulted in an early (day 5) increase in levels of macrophage and granulocyte activation, as well as enhanced effector T cell responses, as measured by both cellularity, cytokine production, and transcriptional profiling. This enhanced acute response led to immune pathology, while blockade during the chronic phase of infection resulted in enhanced T cell responses but no systemic pathology. In the absence of IL-27, the enhanced monocyte responses observed at day 10 were a secondary consequence of activated CD4 + T cells. Thus, in WT mice, IL-27 has distinct suppressive effects that impact innate and adaptive immunity during different phases of this infection. IMPORTANCE: The molecule IL-27 is critical in limiting the immune response to the parasite Toxoplasma gondii . In the absence of IL-27, a lethal, overactive immune response develops during infection. However, when exactly in the course of infection this molecule is needed was unclear. By selectively inhibiting IL-27 during this parasitic infection, we discovered that IL-27 was only needed during, but not prior to, infection. Additionally, IL-27 is only needed in the active areas in which the parasite is replicating. Finally, our work found that a previously unstudied cell type, monocytes, was regulated by IL-27, which contributes further to our understanding of the regulatory networks established by this molecule.Keywords
Funding Information
- HHS | National Institutes of Health (F31AI161962)
- HHS | National Institutes of Health (U01AI160664)
This publication has 53 references indexed in Scilit:
- IL-27 Receptor Signalling Restricts the Formation of Pathogenic, Terminally Differentiated Th1 Cells during Malaria Infection by Repressing IL-12 Dependent SignalsPLOS Pathogens, 2013
- The Toxoplasma gondii Peptide AS15 Elicits CD4 T Cells That Can Control Parasite BurdenInfection and Immunity, 2012
- NK Cell-Derived Interferon-γ Orchestrates Cellular Dynamics and the Differentiation of Monocytes into Dendritic Cells at the Site of InfectionImmunity, 2012
- Essential Role for IL-27 Receptor Signaling in Prevention of Th1-Mediated Immunopathology during Malaria InfectionThe Journal of Immunology, 2010
- Differential Regulation of Effector- and Central-Memory Responses to Toxoplasma gondii Infection by IL-12 Revealed by Tracking of Tgd057-Specific CD8+ T CellsPLOS Pathogens, 2010
- IL-27 Regulates IL-10 and IL-17 from CD4+ Cells in Nonhealing Leishmania major InfectionThe Journal of Immunology, 2009
- Gr1+ Inflammatory Monocytes Are Required for Mucosal Resistance to the Pathogen Toxoplasma gondiiImmunity, 2008
- Interleukin-27 directly induces differentiation in hematopoietic stem cellsBlood, 2008
- Expression of IL-27 p28 by Theiler's virus-infected macrophages depends on TLR3 and TLR7 activation of JNK-MAP-kinasesAntiviral Research, 2007
- Protection from lethal septic peritonitis by neutralizing the biological function of interleukin 27Journal of Experimental Medicine, 2006